Deciphera Pharmaceuticals, Inc. Payments to Acquire in Process Research and Development
Deciphera Pharmaceuticals, Inc. reported Payments to Acquire in Process Research and Development of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-07.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment · last filed 2024-02-07
- Deciphera Pharmaceuticals, Inc. payments to acquire in process research and development for the quarter ending 2022-12-31 was $0.00.
- Deciphera Pharmaceuticals, Inc. payments to acquire in process research and development for the quarter ending 2021-12-31 was $0.00.
- Deciphera Pharmaceuticals, Inc. payments to acquire in process research and development for the quarter ending 2020-12-31 was $0.00.
- Deciphera Pharmaceuticals, Inc. payments to acquire in process research and development for fiscal 2023 was $0.00.
- Deciphera Pharmaceuticals, Inc. payments to acquire in process research and development for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Deciphera Pharmaceuticals, Inc. payments to acquire in process research and development for fiscal 2021 was $4.00M.
- Deciphera Pharmaceuticals, Inc. payments to acquire in process research and development for fiscal 2020 was $0.00.
| Period end | Payments to Acquire in Process Research and Development 3 month | Payments to Acquire in Process Research and Development 9 month | Payments to Acquire in Process Research and Development 12 month |
|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-07 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $0.00 10-K · filed 2024-02-07 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-03 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $4.00M 10-K · filed 2024-02-07 | |
| 2021-09-30 | $4.00M 10-Q · filed 2022-11-03 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $0.00 10-K · filed 2023-02-07 | |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-02 | ||
| 2019-12-31 | $0.00 10-K · filed 2022-02-08 |